In the quest for youthful and vibrant skin, advancements in cosmetic dermatology continually offer novel solutions. One such innovation garnering attention is calcium hydroxylapatite (CaHA), a compound showing promising results in aesthetic enhancement.
In a recent systematic review and analysis led by Epistudia team, we shed light on the efficacy and satisfaction associated with CaHA injections, highlighting its potential to rejuvenate both facial and hand regions, while also exploring their potential for other parts of the body.
Our
study, published in the Journal of Clinical Medicine, meticulously evaluated controlled clinical trials to understand CaHA's impact on aesthetic outcomes, skin-aging-related parameters, and patient satisfaction. Among 2120 references screened, 13 published clinical trials met the inclusion criteria, providing valuable insights into CaHA's effectiveness.
Primarily focusing on facial areas and the dorsum of the hand, the analysis revealed consistent enhancements across various aesthetic parameters. Notably, CaHA injections demonstrated significant improvements in the global aesthetic improvement scale, indicating favorable outcomes in both facial and hand regions. Patients exhibited high levels of satisfaction following CaHA treatments, particularly in facial areas such as nasolabial folds and the jawline. Furthermore, the studies underscored CaHA's versatility in addressing skin aging concerns, with notable reductions observed in facial wrinkles and improvements in hand grading scales.
However, amidst the promising results, our study acknowledges the presence of methodological limitations and heterogeneous comparison groups in the reviewed trials. Thus, while the evidence points towards the positive effects of CaHA, further controlled clinical trials are warranted to better understand its applications and advantages comprehensively.
This study's findings are important for cosmetic dermatology. CaHA shows promise for practitioners, giving patients a non-invasive way to meet their aesthetic goals. It tackles skin aging, with patients being happy with the results. Continued research efforts will deepen our comprehension of CaHA's clinical applications.
